Study to genotype six common diseases

October 10, 2006

Six common diseases have been selected as the first to undergo whole genome analysis by the U.S. Genetic Association Information Network.

The Foundation for the National Institutes of Health says the type of analysis to be obtained is designed to identify the genetic contributions to common illnesses that affect the public health.

The six diseases are: psoriasis, attention deficit hyperactivity disorder, schizophrenia, bipolar disorder, major depression and anxiety, and diabetic nephropathy.

Using biological samples collected during earlier clinical studies, GAIN will evaluate the subtle differences between the genomes of approximately 1,000-2,000 healthy volunteers and the genomes of 1,000-2,000 patients with the condition being studied. Scientists say identifying genetic differences between the two groups will speed development of methods to prevent, diagnose, treat and even cure common conditions.

The Genetic Association Information Network is a public-private partnership involving the National Institutes of Health; Pfizer Inc.; Affymetrix Inc., of Santa Clara, Calif.; Perlegen Sciences Inc. of Mountain View, Calif.; Abbott Laboratories of Abbott Park, Ill.; and the Broad Institute of the Massachusetts Institute of Technology and Harvard University.

Copyright 2006 by United Press International


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


October 10, 2006 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Gene therapy and stem cells save limb
    created 4 hours ago | popularity not rated yet | comments 0
  • Superior offspring without genetic modification
    created 8 hours ago | popularity not rated yet | comments 0
  • Antioxidant compound reduced incidence of colorectal metachronous adenomas
    created 15 hours ago | popularity not rated yet | comments 0
  • Antidepressant Can Change Patient's Personality
    created Dec 07, 2009 | popularity not rated yet | comments 0
  • New approach to sickle-cell disease shows promise in mice
    created Dec 07, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

Think again about keeping little ones so squeaky clean

Medicine & Health / Research

created 1hour ago | popularity 5 / 5 (4) | comments 0

A new Northwestern University study suggests that American parents should ease up on antibacterial soap and perhaps allow their little ones a romp or two in the mud --- or at least a much better acquaintance with everyday ...


Grinch likely depressed, suffers from lack of love, joy, expert says (w/ Video)

Medicine & Health / Psychology & Psychiatry

created 2 hours ago | popularity 5 / 5 (2) | comments 0

(PhysOrg.com) -- Being irritable, grumpy and seeking social isolation are also hallmarks of depression, and could explain the Grinch's disdain for the Who -- the tall and the small -- his mistreatment of his dog Max and, ...


Testosterone does not induce aggression

Medicine & Health / Neuroscience

created 6 hours ago | popularity 4.3 / 5 (3) | comments 2

New scientific evidence refutes the preconception that testosterone causes aggressive, egocentric, and risky behavior. A study at the Universities of Zurich and Royal Holloway London with more than 120 experimental subjects ...


Possible ovarian cancer treatment target identified

Medicine & Health / Cancer

created 3 hours ago | popularity not rated yet | comments 0

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called ...


Cut out the (estrogen) middleman

Medicine & Health / Neuroscience

created 6 hours ago | popularity not rated yet | comments 0

Estrogen seems to act like a middleman in its positive effect on the brain, raising the possibility that future drugs may bypass the carcinogenic hormone altogether while reaping its benefits.